RMD - ResMed Inc.
NEXT EARNINGS:
Apr 22, 2026
EPS Est: $2.77
|
Rev Est: $1.4B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$295.88
DETAILS
HIGH:
$345.00
LOW:
$265.00
MEDIAN:
$291.50
CONSENSUS:
$295.88
UPSIDE:
17.59%
Market Cap:
36.73B
Volume:
872,905
Avg Volume:
1,038,815
52 Week Range:
199.92-293.81
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.88
Last Dividend:
$2.33
Exchange:
NYSE
Country:
US
Employees:
9,980
IPO Date:
1995-06-02
EPS (TTM):
9.55
P/E Ratio:
27.02
Revenue (TTM):
5.15B
Total Assets:
8.17B
Total Debt:
851.81M
Cash & Equiv:
1.21B
Rev Growth (5Y):
11.7%
EPS Growth (5Y):
17.3%
FCF Growth (5Y):
19.0%
ROCE:
23.4%
Debt/Equity:
0.14
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-29 | $2.81 | $2.74 | +2.6% | $1.4B | $1.4B | +1.6% |
| 2025-10-30 | $2.55 | $2.51 | +1.6% | $1.3B | $1.3B | +0.2% |
| 2025-07-31 | $2.55 | $2.55 | 0.0% | $1.3B | $1.3B | 0.0% |
| 2025-04-23 | $2.37 | $2.38 | -0.4% | $1.3B | $1.3B | +0.3% |
| 2025-01-30 | $2.43 | $2.32 | +4.7% | $1.3B | $1.3B | +1.2% |
| 2024-10-24 | $2.20 | $2.04 | +7.8% | $1.2B | $1.2B | +3.3% |
| 2024-08-01 | $2.08 | $2.07 | +0.5% | $1.2B | $1.2B | +0.4% |
| 2024-04-25 | $2.13 | $1.91 | +11.5% | $1.2B | $1.2B | +1.9% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.15B | 4.69B | 4.22B | 3.58B | 3.20B | 2.96B | 2.61B | 2.34B | 2.07B | 1.84B | 1.68B | 1.55B |
| Net Income | 1.40B | 1.02B | 897.56M | 779.44M | 474.50M | 621.67M | 404.59M | 315.59M | 342.28M | 352.41M | 352.89M | 345.27M |
| EPS | 9.55 | 6.94 | 6.12 | 5.34 | 3.27 | 4.31 | 2.83 | 2.21 | 2.42 | 2.51 | 2.51 | 2.44 |
| Total Assets | 8.17B | 6.87B | 6.75B | 5.10B | 4.73B | 4.59B | 4.11B | 3.06B | 3.47B | 3.26B | 2.18B | 2.36B |
| Total Debt | 851.81M | 873.93M | 1.58B | 917.55M | 793.72M | 1.30B | 1.27B | 281.45M | 1.08B | 1.17B | 300.59M | 300.79M |
| Cash & Equivalents | 1.21B | 238.36M | 227.89M | 273.71M | 295.28M | 463.16M | 147.13M | 188.70M | 821.93M | 731.43M | 717.25M | 905.73M |
| Operating Cash Flow | 1.75B | 1.40B | 693.30M | 351.15M | 736.72M | 802.25M | 459.05M | 505.03M | 414.05M | 547.93M | 383.18M | 391.27M |
| Free Cash Flow | 1.66B | 1.29B | 559.30M | 195.11M | 619.89M | 696.32M | 381.71M | 433.57M | 342.58M | 480.10M | 311.24M | 310.11M |
| FCF per Share | 11.33 | 8.75 | 3.81 | 1.34 | 4.27 | 4.82 | 2.67 | 3.04 | 2.42 | 3.42 | 2.22 | 2.19 |
| Book Value | 5.97B | 4.86B | 4.13B | 3.36B | 2.89B | 2.50B | 2.07B | 2.06B | 1.96B | 1.69B | 1.59B | 1.76B |
| Cash & ST Investments | 1.21B | 238.36M | 227.89M | 273.71M | 295.28M | 463.16M | 147.13M | 188.70M | 821.93M | 731.43M | 717.25M | 905.73M |
| ROC Equity | 0.23 | 0.21 | 0.22 | 0.23 | 0.16 | 0.25 | 0.20 | 0.15 | 0.17 | 0.21 | 0.22 | 0.20 |